Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Inhibrx Biosciences, Inc. (INBX)

71.78 -1.87 (-2.54%)
At close: October 30 at 4:00:01 PM EDT
71.78 0.00 (0.00%)
After hours: October 30 at 4:00:09 PM EDT
Trade INBX on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
1,300
200
1,800
1,301
Operating Expense
127,811
136,325
331,648
221,021
116,624
Operating Income
-127,811
-135,025
-331,448
-219,221
-115,323
Net Non Operating Interest Income Expense
-10,202
-4,647
-2,551
-19,923
--
Other Income Expense
-165
-381
2,021,573
-580
1
Pretax Income
-138,178
-140,053
1,687,574
-239,724
-115,322
Tax Provision
3
2
2
3
3
Earnings from Equity Interest Net of Tax
--
--
0
-1,634
0
Net Income Common Stockholders
-138,181
-140,055
1,687,572
-241,361
-115,325
Diluted NI Available to Com Stockholders
-138,181
-140,055
1,687,572
-241,361
-115,325
Basic EPS
-8.88
-9.04
114.01
-16.95
-8.10
Diluted EPS
-8.88
-9.04
112.62
-16.95
-8.10
Basic Average Shares
15,566.50
15,487
14,802
14,241.18
14,241.18
Diluted Average Shares
15,566.50
15,487
14,984
14,241.18
14,241.18
Total Operating Income as Reported
-127,811
-135,025
-331,448
-219,221
-115,323
Total Expenses
127,811
136,325
331,648
221,021
116,624
Net Income from Continuing & Discontinued Operation
-138,181
-140,055
1,687,572
-241,361
-115,325
Normalized Income
-138,181
-140,055
-333,923.60
-241,361
-115,325
Interest Income
5,366
7,549
10,940
11,917
--
Interest Expense
15,568
12,196
13,491
31,840
--
Net Interest Income
-10,202
-4,647
-2,551
-19,923
--
EBIT
-122,610
-127,857
1,701,065
-207,884
-115,323
EBITDA
-120,403
-125,374
1,703,350
-206,693
-114,098
Reconciled Depreciation
2,207
2,483
2,285
1,191
1,225
Net Income from Continuing Operation Net Minority Interest
-138,181
-140,055
1,687,572
-241,361
-115,325
Total Unusual Items Excluding Goodwill
0
0
2,021,498
0
--
Total Unusual Items
0
0
2,021,498
0
--
Normalized EBITDA
-120,403
-125,374
-318,148
-206,693
-114,098
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
2.40
0
0
12/31/2022 - 5/29/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: